BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31617997)

  • 1. Tumor-Associated Fibroblast-Targeted Regulation and Deep Tumor Delivery of Chemotherapeutic Drugs with a Multifunctional Size-Switchable Nanoparticle.
    Cun X; Chen J; Li M; He X; Tang X; Guo R; Deng M; Li M; Zhang Z; He Q
    ACS Appl Mater Interfaces; 2019 Oct; 11(43):39545-39559. PubMed ID: 31617997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A size switchable nanoplatform for targeting the tumor microenvironment and deep tumor penetration.
    Cun X; Li M; Wang S; Wang Y; Wang J; Lu Z; Yang R; Tang X; Zhang Z; He Q
    Nanoscale; 2018 May; 10(21):9935-9948. PubMed ID: 29770822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Size-shrinkable and protein kinase Cα-recognizable nanoparticles for deep tumor penetration and cellular internalization.
    Ma JB; Shen JM; Yue T; Wu ZY; Zhang XL
    Eur J Pharm Sci; 2021 Apr; 159():105693. PubMed ID: 33383133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatment.
    Hu G; Chun X; Wang Y; He Q; Gao H
    Oncotarget; 2015 Dec; 6(38):41258-74. PubMed ID: 26517810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin-mediated active tumor targeting and tumor microenvironment response dendrimer-gelatin nanoparticles for drug delivery and tumor treatment.
    Hu G; Zhang H; Zhang L; Ruan S; He Q; Gao H
    Int J Pharm; 2015 Dec; 496(2):1057-68. PubMed ID: 26598487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-responsive peptide dendrimer-gemcitabine conjugate as a controlled-release drug delivery vehicle with enhanced antitumor efficacy.
    Zhang C; Pan D; Li J; Hu J; Bains A; Guys N; Zhu H; Li X; Luo K; Gong Q; Gu Z
    Acta Biomater; 2017 Jun; 55():153-162. PubMed ID: 28259838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging strategies against tumor-associated fibroblast for improved the penetration of nanoparticle into desmoplastic tumor.
    Yunna C; Mengru H; Fengling W; Lei W; Weidong C
    Eur J Pharm Biopharm; 2021 Aug; 165():75-83. PubMed ID: 33991610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin.
    Miao L; Wang Y; Lin CM; Xiong Y; Chen N; Zhang L; Kim WY; Huang L
    J Control Release; 2015 Nov; 217():27-41. PubMed ID: 26285063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved tumor tissue penetration and tumor cell uptake achieved by delayed charge reversal nanoparticles.
    Gou J; Liang Y; Miao L; Guo W; Chao Y; He H; Zhang Y; Yang J; Wu C; Yin T; Wang Y; Tang X
    Acta Biomater; 2017 Oct; 62():157-166. PubMed ID: 28827183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Delivery Prodigiosin to Choriocarcinoma by Peptide-Guided Dendrigraft Poly-l-lysines Nanoparticles.
    Zhao K; Li D; Cheng G; Zhang B; Han J; Chen J; Wang B; Li M; Xiao T; Zhang J; Zhou D; Jin Z; Fan X
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system.
    Chen B; Dai W; Mei D; Liu T; Li S; He B; He B; Yuan L; Zhang H; Wang X; Zhang Q
    J Control Release; 2016 Nov; 241():68-80. PubMed ID: 27641831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum-Based Nanovectors Engineered with Immuno-Modulating Adjuvant for Inhibiting Tumor growth and Promoting Immunity.
    Liu L; Chen Q; Ruan C; Chen X; Zhang Y; He X; Zhang Y; Lu Y; Guo Q; Sun T; Wang H; Jiang C
    Theranostics; 2018; 8(11):2974-2987. PubMed ID: 29896297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable nanoparticles composed of dendrigraft poly-L-lysine for gene delivery.
    Kodama Y; Nakamura T; Kurosaki T; Egashira K; Mine T; Nakagawa H; Muro T; Kitahara T; Higuchi N; Sasaki H
    Eur J Pharm Biopharm; 2014 Aug; 87(3):472-9. PubMed ID: 24813391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
    Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL
    Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational Design of Nanoparticles to Overcome Poor Tumor Penetration and Hypoxia-Induced Chemotherapy Resistance: Combination of Optimizing Size and Self-Inducing High Level of Reactive Oxygen Species.
    Deng L; Feng Z; Deng H; Jiang Y; Song K; Shi Y; Liu S; Zhang J; Bai S; Qin Z; Dong A
    ACS Appl Mater Interfaces; 2019 Sep; 11(35):31743-31754. PubMed ID: 31389686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma.
    Zhang J; Zhang M; Ji J; Fang X; Pan X; Wang Y; Wu C; Chen M
    Pharm Res; 2015 Oct; 32(10):3376-90. PubMed ID: 26148773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors.
    Miao L; Liu Q; Lin CM; Luo C; Wang Y; Liu L; Yin W; Hu S; Kim WY; Huang L
    Cancer Res; 2017 Feb; 77(3):719-731. PubMed ID: 27864344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformable nanoparticles triggered by cancer-associated fibroblasts for improving drug permeability and efficacy in desmoplastic tumors.
    Hou L; Chen D; Hao L; Tian C; Yan Y; Zhu L; Zhang H; Zhang Y; Zhang Z
    Nanoscale; 2019 Nov; 11(42):20030-20044. PubMed ID: 31612175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
    Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
    Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges.
    Li W; Little N; Park J; Foster CA; Chen J; Lu J
    Mol Pharm; 2021 Aug; 18(8):2889-2905. PubMed ID: 34260250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.